Enhancing CAR T cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors
M. Righi, I. Gannon, M. Robson, S. Srivastava, E. Kokalaki, T. Grothier, F. Nannini, C. Allen, B. Yuchen, J. Sillibourne, S. P. Cordoba, S. Thomas, M. Pule
This paper introduces a dimerization domain from IgG1 antibodies to create engineered cytokine receptors that mimic natural heterodimerization, enhancing CAR T cell therapy efficacy.
Cancer Immunology Research · Jun 23, 2023Peer-reviewedImmunology